PARN
Poly(A)-specific ribonuclease PARN
Also known as: DAN, PARN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95453
- Gene
- PARN
- Ensembl
- ENSG00000140694
- Chromosome
- 16
- Canonical length
- 639 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a 3'-exoribonuclease, with similarity to the RNase D family of 3'-exonucleases. It prefers poly(A) as the substrate, hence, efficiently degrades poly(A) tails of mRNAs. Exonucleolytic degradation of the poly(A) tail is often the first step in the decay of eukaryotic mRNAs. This protein is also involved in silencing of certain maternal mRNAs during oocyte maturation and early embryonic development, as well as in nonsense-mediated decay (NMD) of mRNAs that contain premature stop codons. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
Canonical amino-acid sequenceUniProt
639 residues, UniProt reviewed canonical sequence.
>O95453|PARN
1 MEIIRSNFKS NLHKVYQAIE EADFFAIDGE FSGISDGPSV SALTNGFDTP EERYQKLKKH
61 SMDFLLFQFG LCTFKYDYTD SKYITKSFNF YVFPKPFNRS SPDVKFVCQS SSIDFLASQG
121 FDFNKVFRNG IPYLNQEEER QLREQYDEKR SQANGAGALS YVSPNTSKCP VTIPEDQKKF
181 IDQVVEKIED LLQSEENKNL DLEPCTGFQR KLIYQTLSWK YPKGIHVETL ETEKKERYIV
241 ISKVDEEERK RREQQKHAKE QEELNDAVGF SRVIHAIANS GKLVIGHNML LDVMHTVHQF
301 YCPLPADLSE FKEMTTCVFP RLLDTKLMAS TQPFKDIINN TSLAELEKRL KETPFNPPKV
361 ESAEGFPSYD TASEQLHEAG YDAYITGLCF ISMANYLGSF LSPPKIHVSA RSKLIEPFFN
421 KLFLMRVMDI PYLNLEGPDL QPKRDHVLHV TFPKEWKTSD LYQLFSAFGN IQISWIDDTS
481 AFVSLSQPEQ VKIAVNTSKY AESYRIQTYA EYMGRKQEEK QIKRKWTEDS WKEADSKRLN
541 PQCIPYTLQN HYYRNNSFTA PSTVGKRNLS PSQEEAGLED GVSGEISDTE LEQTDSCAEP
601 LSEGRKKAKK LKRMKKELSP AGSISKNSPA TLFEVPDTWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 23 nTPM
- tonsil: 22 nTPM
- blood vessel: 21 nTPM
- thymus: 20 nTPM
- parathyroid gland: 20 nTPM
- lymph node: 19 nTPM
Single-cell type
- choroid plexus epithelial cells: 130 nCPM
- microglia: 114 nCPM
- renal collecting duct intercalated cells: 113 nCPM
- distal convoluted tubule cells: 110 nCPM
- renal connecting tubule cells: 109 nCPM
- proximal tubule cells: 103 nCPM
Immune cell
- T-reg: 18 nTPM
- memory B-cell: 16 nTPM
- non-classical monocyte: 16 nTPM
- eosinophil: 15 nTPM
- naive CD8 T-cell: 15 nTPM
- NK-cell: 15 nTPM
Brain region
- hypothalamus: 17 nTPM
- white matter: 16 nTPM
- cerebellum: 15 nTPM
- pons: 14 nTPM
- choroid plexus: 14 nTPM
- basal ganglia: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PARN.
Disease | AllUniProt
Conditions PARN is implicated in, by any mechanism.
- Dyskeratosis congenita, autosomal recessive, 6 (DKCB6) MIM:616353
- Pulmonary fibrosis, and/or bone marrow failure syndrome, telomere-related, 4 (PFBMFT4) MIM:616371
Disease | GeneticClinVar
86 pathogenic / likely-pathogenic of 977 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4
- Dyskeratosis congenita, autosomal recessive 6
- Pulmonary fibrosis
- Familial Interstitial Pneumonia
- Dyskeratosis congenita
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.79
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- box H/ACA sno(s)RNA 3'-end processing
- female gamete generation
- lncRNA processing
- miRNA catabolic process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- nuclear-transcribed mRNA poly(A) tail shortening
- poly(A)-dependent snoRNA 3'-end processing
- positive regulation of telomere maintenance via telomerase
- priRNA 3'-end processing
- regulation of telomerase RNA localization to Cajal body
- RNA modification
- siRNA 3'-end processing
- telomerase RNA stabilization
Molecular functions
- 3'-5'-RNA exonuclease activity
- cation binding
- metal ion binding
- mRNA 3'-UTR binding
- nuclease activity
- poly(A)-specific ribonuclease activity
- protein kinase binding
- RNA binding
- telomerase RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- R3H domain
- Ribonuclease CAF1
- Ribonuclease H-like superfamily
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- Ribonuclease H superfamily
- R3H domain superfamily
- CAF1 family poly(A)-specific ribonucleases
- CAF1 family ribonuclease
- Poly(A)-specific ribonuclease, RNA-binding
- PARN, R3H domain
- RNA binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARN as an antibody target. Whether an autoantibody or antibody against PARN could matter depends on whether native PARN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PARN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...